Patent classifications
A23J3/08
MEAT ANALOGUE PROCESSED FOOD PRODUCT, METHOD FOR PRODUCING SAME, AND ADDITIVE FOR MEAT ANALOGUE PROCESSED FOOD PRODUCT
The present invention provides a meat analogue processed food product that is inexpensive and has little pastiness derived from starch, a method for producing the meat analogue processed food product, and an additive for the meat analogue processed food product. The meat analogue processed food product, which contains a plant-protein-containing material and has a meat material content of 30 mass % or less, also contains a fat-processed starch as a raw material. The fat-processed starch content is preferably 0.5-10 mass %. Furthermore, the meat analogue processed food product preferably also contains one or more material selected from animal-sourced protein materials excluding the meat material and plant-sourced protein materials excluding the plant-protein-containing material, in which the animal-sourced protein materials are preferably selected from a milk protein material and an albumen, the plant-sourced protein materials are preferably selected form a pea protein material and a wheat protein material, and ideally the food product contains an albumen.
METHOD FOR PROCESSING A DAIRY PROTEIN COMPOSITION IN ORDER TO PRODUCE A LACTOSE-RICH LIQUID COMPOSITION
A method for the processing a dairy protein composition in order to obtain a lactose-rich liquid composition, including an ultrafiltration step (ii) in order to obtain an ultrafiltration permeate and an ultrafiltration retentate; followed by a processing step (iv) on ion-exchange resins, including at least one pass including percolation over a cationic resin followed by percolation over an anionic resin.
METHOD FOR PROCESSING A DAIRY PROTEIN COMPOSITION IN ORDER TO PRODUCE A LACTOSE-RICH LIQUID COMPOSITION
A method for the processing a dairy protein composition in order to obtain a lactose-rich liquid composition, including an ultrafiltration step (ii) in order to obtain an ultrafiltration permeate and an ultrafiltration retentate; followed by a processing step (iv) on ion-exchange resins, including at least one pass including percolation over a cationic resin followed by percolation over an anionic resin.
Milk Based Compositions Comprising Milk Derived, Denatured Retentate
The invention relates to the use of milk derived, denatured retentate in the preparation of milk-based compositions, which may be aerated or non-aerated, comprise a skimmed mild source, and/or have less than 0.5% w/w fat. The milk derived, denatured retentate allows the formation of microbubbles in an aerated skimmed milk composition, and thus retains certain desirable sensory perception characteristics such as a good mouthfeel and perceived thickness.
Milk Based Compositions Comprising Milk Derived, Denatured Retentate
The invention relates to the use of milk derived, denatured retentate in the preparation of milk-based compositions, which may be aerated or non-aerated, comprise a skimmed mild source, and/or have less than 0.5% w/w fat. The milk derived, denatured retentate allows the formation of microbubbles in an aerated skimmed milk composition, and thus retains certain desirable sensory perception characteristics such as a good mouthfeel and perceived thickness.
Thixotropic α-lactalbumin hydrogels, method for preparing same and uses thereof
The present invention relates to shear-thinning α-lactalbumin hydrogels, which have a threshold and are thixotropic, to a method for preparing same and to the use thereof.
Thixotropic α-lactalbumin hydrogels, method for preparing same and uses thereof
The present invention relates to shear-thinning α-lactalbumin hydrogels, which have a threshold and are thixotropic, to a method for preparing same and to the use thereof.
Molecular origin of allergy
The present invention relates to compositions and methods for modulating or detecting allergy in a subject. The invention may be used to reduce allergenicity of compositions, such as food products, or to stimulate immunogenicity of products, such as vaccines by removal of cationic proteins resulting from transcription infidelity. The invention may be used in any mammal such as human.
Molecular origin of allergy
The present invention relates to compositions and methods for modulating or detecting allergy in a subject. The invention may be used to reduce allergenicity of compositions, such as food products, or to stimulate immunogenicity of products, such as vaccines by removal of cationic proteins resulting from transcription infidelity. The invention may be used in any mammal such as human.
Casein glycomacropeptide (CGMP) oligomers
A method for making a new food, feed or pharmaceutical product comprising addition of a composition comprising cross-linked, via intermolecular covalent isopeptide bonds, casein glycomacropeptide (CGMP) oligomers (CGMP oligomers) to the product.